News of Note—U.K. research hub, Bavarian Nordic and more

newspaper
In this week's news of note, Bavarian Nordic named a new CFO. (Pixabay)

Here is some other vaccine news of note for the week.

> Officials in the U.K. outlined a plan for a vaccine research hub to help prevent and respond to outbreaks more effectively. Release

> Bavarian Nordic appointed Henrik Juuel, who has served at Novo Nordisk and Virgin Mobile, as its new CFO. Release

Survey

Survey: The Critical Role of Innovation in Launching Successful OTC Products

This research aims to understand the importance of product innovation and dose forms in driving new product design and development, consumer engagement and purchase interest for Over-the-Counter medicines. The first 50 qualified respondents will receive a $5 Amazon gift card. Take the survey now.

> In an animal study, National Institute of Allergy and Infectious Diseases researchers reported that an HIV vaccine targeting a vulnerable site on the virus elicited antibodies against dozens of strains from around the world. Release

Suggested Articles

After countless headlines from a Dengvaxia safety scandal in the Philippines, officials are now considering using the Sanofi vaccine again.

Merck's oncology superstar Keytruda has been stealing the spotlight, but in vaccines, the drugmaker has growth figures to tout.

Experts are pushing for the introduction of J&J's vaccine in the response to the Ebola outbreak in the Democratic Republic of Congo.